Trilogy International Partners Inc (TSE:TRL) had its price target lowered by investment analysts at Scotiabank from C$12.50 to C$11.00 in a research report issued on Thursday. The firm currently has an “outperform” rating on the specialty pharmaceutical company’s stock. Scotiabank’s target price indicates a potential upside of 38.36% from the stock’s previous close.

Separately, TD Securities reaffirmed a “hold” rating and set a C$11.50 price target on shares of Trilogy International Partners in a report on Friday, April 28th.

Shares of Trilogy International Partners (TRL) traded down 1.89% during mid-day trading on Thursday, reaching $7.80. 1,000 shares of the company’s stock traded hands. Trilogy International Partners has a 12 month low of $7.80 and a 12 month high of $10.48. The stock’s market cap is $344.58 million. The firm has a 50 day moving average price of $8.41 and a 200-day moving average price of $9.35.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at

About Trilogy International Partners

Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.

Receive News & Ratings for Trilogy International Partners Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.